7. Allergan

Total Ad Spend: $193.1 million
Television: $85.9 million
Magazine: $107.2 million
Other: $236,000

One of the interesting things about Allergan's ($AGN) strategy is that it puts more of its ad money into magazine advertising than television, the only one in the top 10 to do that. Its advertising for using Botox for migraines paid off, pumping up sales of the drug 14.5% in its 2012 fourth quarter.

In the spotlight

Restasis, $56.7 milion
Botox for migraines, $37.5 million
Botox for wrinkles, $31.2 million



Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.